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ABSTRACT  31 
Purpose: This study examined the acute effects of a single session of 32 
Whole-body Cryotherapy (WBC) following severe intermittent running 33 
exercise on biomarkers of inflammation, muscle damage and stress.  34 
Methods: Endurance-trained males (n=11) were tested twice using a within-35 
participant, balanced cross-over design that consisted of 5 x 5 min of high-36 
intensity running (HIR) followed by either 3 min of WBC at -110°C or a 37 
passive control condition (CON). Before the HIR and after 60 min of recovery 38 
a ramp-test was completed. At seven time points up to 24 hrs post exercise 39 
venous blood samples were analyzed for serum levels of interleukin 6 (IL-40 
6), interleukin 10 (IL-10), c-reactive protein (CRP), soluble intercellular 41 
adhesion molecule-1 (sICAM-1), myoglobin, cortisol, and testosterone.  42 
Results: HIR induced significant increases in all biomarkers except sICAM-43 
1 in both recovery conditions, respectively. Compared to the CON condition 44 
WBC did not attenuate exercise- induced changes in IL-6, IL-10, sICAM-1, 45 
myoglobin, cortisol, testosterone or their ratio. Increased levels of cortisol 46 
following exercise were negatively correlated with subsequent running 47 
performance in both conditions (WBC: r = -0.61, p = 0.04; CON: r = -0.64, p 48 
= 0.04).  49 
Conclusion: The results of this study suggest that the postulated 50 
physiological mechanisms by which WBC is proposed to improve recovery, 51 
i.e. reductions in inflammation and muscle damage, may not be accurate. 52 
 53 
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 56 
HIGHLIGHTS 57 
• WBC did not affect changes in IL-6, IL-10, or myoglobin after high-58 
intensity exercise 59 
• Similar data were recorded for testosterone, cortisol, and their ratio 60 
• sICAM-1 was not altered by intermittent exercise or WBC 61 
• ∆cortisol following exercise was negatively correlated  with subsequent 62 
performance  63 
 64 
  65 
1. INTRODUCTION  66 
Whole-body Cryotherapy (WBC) or cryostimulation is a popular and widely 67 
used recovery modality in sport and exercise medicine following intensive 68 
training and competition.  It consists of brief exposures (typically 2 to 4 69 
minutes) to very cold air (-110°C and below) in cryogenic chambers with 70 
individuals minimally dressed [1,2]. Originally utilized in a clinical setting for 71 
treating symptoms of various rheumatic diseases, WBC is purported to 72 
reduce pain, edema, and inflammation [3]. Therefore, WBC has become 73 
very popular with both recreational and elite athletes.. To date, there is a 74 
limited body of evidence regarding its efficacy and empirical data detailing 75 
the potential mechanism(s) by which this treatment could be effective is 76 
sparse [1].  77 
Several authors have speculated that reductions in inflammation is the 78 
primary mechanism by which WBC after strenuous exercise is believed to 79 
be effective [1,2,5]. It is well established that intense exercise, especially if 80 
the athlete is unaccustomed to such modalities and/or the exercise is 81 
eccentric [6], leads to sarcomere disruptions and cell membrane damage 82 
[7]. Following cell damage leukocytes are mobilized to the injured tissue by 83 
soluble intercellular adhesion molecule-1 (sICAM-1), producing reactive 84 
oxygen species and pro-inflammatory cytokines in the injured tissue, 85 
resulting in intramuscular degradation and an amplification of muscle 86 
damage [8]. This mechanism is defined as secondary muscle damage [8] 87 
and  may also be related to the increased levels of pro- and anti-88 
inflammatory cytokines observed following exercise [9]. It is believed that 89 
exercise- induced inflammation, e.g. indicated by augmented Interleukin 90 
(IL)-6 impairs athletic performance [10,11]. As WBC reduces skin-, muscle- 91 
and core-temperature [12], leading to vasoconstriction and reduced blood 92 
vessel permeability to immune cells, it is plausible that fewer leukocytes are 93 
mobilized to the injured tissue, leading to a reduced pro-inflammatory 94 
response and consequently less secondary muscle damage [13]. However, 95 
the recent debate regarding the effects of WBC on modulating the 96 
expression of sICAM-1 is still inconsistent and conflicting [5,14], possibly due 97 
to the timing of the intervention post exercise. [14]To the best of our 98 
knowledge, the effect of WBC on sICAM-1 following intense exercise has 99 
not been compared to a control intervention. 100 
Several studies have investigated the physical, psychological, and 101 
physiological effects of WBC following exercise (for a review see [1,2,15]) 102 
Many [13,16–19], but not all [20,21] have reported that WBC might facilitate  103 
the  recovery process after exercise. Actually, for most biomarkers (e.g. pro- 104 
and anti-inflammatory cytokines, creatinkinase (CK)) contradictory findings 105 
have been reported in the literature. These conflicting results may be due to 106 
large differences in methodology, such as exercise duration and intensity, 107 
numbers of exercise bouts and WBC sessions and time points of biomarker 108 
assessment. Thus, practical applications and recommendations for athletes 109 
and their coaches are often difficult to conclude. As daily high-quality 110 
performance and multiple competitions per week are required in many 111 
sports, athletes often require interventions to enhance recovery within hours 112 
or a few days. To date, only a few studies [13,16,19–23] investigated the 113 
effects of a single WBC-treatment on acute recovery after high-intensity 114 
exercise.  In nine well-trained runners, performing a simulated trail run peak 115 
torques of the knee extensors along with perceived sensation of pain and 116 
tiredness was not significantly different  in the WBC recovery condition 117 
compared to passive rest [13]. With regard to biomarkers, no strong 118 
conclusions can be made as alterations in some biomarkers (C-reactive 119 
protein (CRP), Interleukin (IL)-1 β, IL-1 ra) indicated reduced inflammation, 120 
while others (IL-6, IL-10, tumor necrosis factor (TNF)-α) remained 121 
unchanged compared to passive recovery [19]. WBC applied after repeated 122 
sprint exercise in professional soccer players induced a greater salivary 123 
testosterone response compared to a control condition, but the changes did 124 
not result in improvements in jump performance, blood lactate, CK 125 
concentrations or perceived recovery [20]. [16][16]Other studies 126 
demonstrated no beneficial effects of WBC on muscle force recovery [21] or 127 
mixed results regarding perceived pain sensation and maximal physical 128 
performance after hamstring damaging exercise [23]. As the majority of 129 
previous studies focused on performance parameters it remains unclear 130 
whether one session in combination with high-intensity exercise alters 131 
biomarkers of hormonal status, inflammation and muscle damage.  132 
Accordingly, the aim of the present study was to investigate the acute effects 133 
of a single WBC-session during intermittent exercise on biomarkers 134 
associated with exercise-induced inflammation, muscle damage and stress. 135 
We hypothesized that a single exposure of WBC would reduce markers of 136 
inflammation and muscle damage, and alter the cortisol-testosterone ratio 137 
following high-intensity intermittent exercise 138 
 139 
2. METHODS 140 
2.1 Participants 141 
A convenient sample size of 11 healthy, endurance-trained, male athletes 142 
participated in the study (mean ± SD age: 25.9 ± 2.1 yrs; height: 183.4 ± 3.4 143 
cm; mass: 76.3 ± 6.6 kg; body mass index: 22.7 ± 1.7 kg.m-2; body fat: 10.7 144 
± 1.9 %; lean body mass: 68.1 ± 5.9 kg; peak oxygen uptake: 59.3 ± 5.3 145 
mL·kg-1·min-1; performance level 3 and 4, according to De Pauw et al. [24]).. 146 
Inclusion criteria involved a history in endurance training (running) of at least 147 
8 years with 3 or more training sessions per week as well as being familiar 148 
with high-intensity interval training, i.e. short intervals of 2-8 min at 90-95% 149 
of maximal heart rate, separated by equally short periods of recovery [25]. 150 
Athletes were excluded if they had any contraindications to WBC, such as 151 
claustrophobia, cold hypersensitivity or abrasion injuries during medical 152 
checkup as described elsewhere [2]. Participants were instructed to refrain 153 
from consuming alcohol and caffeine 24 hrs prior to the tests and to maintain 154 
their normal diet during the testing period. Intensive exercise was not 155 
permitted for up to 48 hrs prior to the two test sessions and the individual 156 
training was identical in the preceding week, respectively. Additional 157 
recovery methods, including the use of non-steroidal anti-inflammatory 158 
drugs, were not permitted. After demonstration and briefing about the 159 
potential risks, all participants provided their written informed consent. The 160 
study was conducted in accordance with the Declaration of Helsinki and 161 
approved by the ethical committee of the German Sports University 162 
Cologne. 163 
2.2 Experimental design 164 
This study was part of a larger project investigating effects of WBC on 165 
performance variables, and the experimental design has been described in 166 
detail elsewhere [16]. Briefly, a within-participant, balanced cross-over 167 
design (with 7-days washout) was employed. Before participation, the 168 
athletes underwent a medical checkup and familiarization with WBC. 169 
Furthermore they carried out an incremental step test (starting velocity: 2.4 170 
m·s-1; increase 0.4 m·s-1 every 5 min; treadmill gradient 1%) on a treadmill 171 
(Woodway ELG 90/200 Sport, Lörrach, Germany) until individual exhaustion 172 
to determine VO2max (MetaLyzer 3b, Cortex, Leipzig, Germany) and the 173 
individual intensities for High-intensity-running (HIR) during the two main 174 
tests. The experimental protocol of these tests is presented in Figure 1. 175 
*** Figure 1 near here*** 176 
All athletes were tested at the same time of day on each occasion and were 177 
randomly assigned to start with either the WBC or control intervention (CON) 178 
using research randomizer (version 4.0, retrieved from 179 
http://www.randomizer.org/). The participants arrived at the laboratory at 180 
least one hour prior to the test for acclimatization. At first, an incremental 181 
exercise protocol to individual exhaustion was performed (Ramp 1). The 182 
protocol consisted of 3 submaximal 3-min steps at 3.2, 3.6 and 4.0 m·s-1 with 183 
a treadmill gradient of 1% and 30 s of rest after each step. Thereafter velocity 184 
was increased to 4.4 m·s-1 and remained constant while the treadmill 185 
gradient was increased by 0.5% every 30 s until exhaustion. After 5 min of 186 
recovery, HIR was carried out, consisting of 5 x 5 min at 90 % of maximum 187 
velocity (Vmax) reached during the step test, with 4 min of active recovery in 188 
between the intervals (60 % of Vmax). HIR was followed by 1 h of passive 189 
recovery, which was identically structured in both conditions except for the 190 
implementation of one 3-min session of WBC after 45 min of rest. During the 191 
recovery period the athletes remained seated in the conditioned laboratory 192 
(ambient laboratory temperature WBC: 21.7 ± 0.8°C vs. CON: 21.7 ± 1.0°C; 193 
humidity WBC: 36.4 ± 7.7% vs. CON: 35.8 ± 8.3%) and consumed 0.5 L of 194 
a standardized fluid intake (energy: 400 kcal consisting of 46.5g 195 
carbohydrates, 15g protein, 17g fat) to avoid dehydration and to replenish 196 
depleted glycogen stores [26]. WBC was performed in a temperature-197 
controlled cryochamber with an electrical cooling system (Zimmer 198 
MedizinSysteme GmbH, Ulm, Germany). The chamber system consists of 199 
three separate rooms with constant temperatures of -10, -60 and -110°C and 200 
we employed a protocol similar to that previously described elsewhere 201 
[2,16]. The participants traversed the first two chambers with -10°C and -202 
60°C quickly and remained slowly walking for 3 min within the room at -203 
110°C. During the control intervention athletes walked slowly within the 204 
laboratory for 3 min (at 21.7 ± 0.8°C and 35.8 ± 8.3 % humidity). After a total 205 
of 60 min of recovery, athletes performed a second incremental exercise 206 
(Ramp 2) with the same design as the first one. Time to exhaustion (tlim) was 207 
defined as the time (sec.) from the beginning of the ramp test until the 208 
athlete´s volitional exhaustion [16]. 209 
2.3 Data measurement 210 
Before and after Ramp 1 + HIR (R1pre, R1post) and Ramp 2 (R2pre, R2post) as 211 
well as 1-, 4- and 24-hrs after finishing the exercise protocol 8.5 mL venous 212 
blood samples was obtained (BD Vacutainer Blood Collection System, 213 
Beckton Dickson & Company, Plymouth, UK) from the antecubital vein 214 
following 10 min of seated rest (see Figure 1). After collection, the samples 215 
were stored at 7 °C for ~30-min for deactivation of coagulation factors before 216 
being centrifuged (1861 g for 10-min at 4°C, Rotixa 50; Hettich Zentrifugen, 217 
Mühlheim, Germany). The serum was then aliquoted (Eppendorf type) at -218 
80°C until later analysis. In particular, we were interested in the inflammatory 219 
markers IL-6, IL-10, CRP and sICAM-1; the hormonal biomarkers cortisol 220 
and testosterone, and the muscle damage biomarker myoglobin. Serum 221 
levels of cortisol (ng·mL-1), testosterone (ng·mL-1), IL-6 (pg·mL-1), IL-10 222 
(pg·mL-1), sICAM-1 (ng·mL-1), CRP (mg·L-1), and myoglobin (ng·mL-1) were 223 
determined using human enzyme-linked immunosorbent assay (ELISA) kits. 224 
Manufacturer instructions were followed for each of the kits and repeated 225 
freeze-thaw cycles of serum were avoided. Intra-assay coefficient of 226 
variations for cortisol, testosterone, c-reactive protein and Myoglobin (ELISA 227 
kits manufactured by DRG Instruments GmbH, Marburg, Germany) as well 228 
as sICAM-1 and IL-10 high sensitive (R&D Systems Inc, Minneapolis, USA) 229 
and IL-6 high sensitive (IBL International GmbH, Hamburg, Germany) was 230 
3.2%, 3.3%, 4.2%, 3.9%, 5.0%, 9.3%, and 4.6%, respectively. Minimum 231 
detectable serum concentrations were 2.5 ng·mL-1 for cortisol, 0.083 ng·mL-232 
1 for testosterone, 0.03 pg·mL-1 for IL-6, 0.09 pg·mL-1 for IL-10, 0.096 ng·mL-233 
1 for sICAM-1, 0.1 mg·L-1 for CRP, and 5.0 ng·mL-1 for myoglobin. 234 
Hematological blood analysis was performed on the day of data collection 235 
for the assessment of white blood cell count (1·10-3·µL-1) using Sysmex KX-236 
21N (Sysmex Deutschland GmbH, Norderstedt, Germany). 237 
2.4 Statistical Analyses 238 
All statistical tests were carried out using the Statistica software package for 239 
Windows® (version 13.0, StatSoft Inc., Tulsa, OK, U.S.A). The distribution of 240 
data was assessed using descriptive methods (skewness, outliers, and 241 
distribution plots) and inferential statistics (Shapiro–Wilk test). As all data 242 
were normally distributed data are presented as means ± standard 243 
deviations (SD). A two way (treatment [WBC, Control] * time [R1pre, R1post, 244 
R2pre, R2post, 1h, 4h, 24h]) repeated-measures analysis of variance 245 
(ANOVA) was applied to compare all biomarkers. If main effects or 246 
interactions were identified, Bonferroni post-hoc analysis was applied where 247 
appropriate. Statistical significance was accepted at P < 0.05. Person 248 
product-moment correlations were used to detect relationships between 249 
ramp tests performance decrements (Δ tlim = tlimR2 – tlimR1) and changes in 250 
cortisol, testosterone, IL-6, IL-10, sICAM-1, CRP, myoglobin, and white 251 
blood cell count from baseline (R1pre) to R2pre in both recovery conditions, 252 
respectively. 253 
 254 
3. RESULTS 255 
The serum concentrations of all biomarkers (mean ± SD) are detailed in 256 
table 1. At baseline (R1pre), similar results were recorded for all outcome 257 
measures (all p > 0.05) and all values were within normal range for healthy 258 
individuals. 259 
3.1 Inflammatory Markers 260 
Significant time effects (p < 0.01) were observed for IL-6 ( Fig 2A) and IL-10 261 
(Fig 2B). No significant intervention or interaction effects were detected for 262 
IL-6 (p = 0.23 and p = 0.51) and IL-10 (p = 0.53 and p = 0.78), respectively. 263 
Compared to baseline (WBC: 0.85 ± 0.56; CON: 0.75 ± 0.41) IL-6 (pg·mL-1) 264 
was significantly higher at R1post (WBC: 2.12 ± 0.99; CON: 1.93 ± 0.51), R2pre 265 
(WBC: 1.19 ± 0.51; CON: 1.18 ± 0.28), R2post (WBC: 1.22 ± 0.56; CON: 1.10 266 
± 0.31) and 1h (WBC: 1.25 ± 0.47; CON: 1.19 ± 0.42) (all p < 0.01). IL-10 267 
(pg·mL-1) was elevated at R1post (WBC: 3.62 ± 2.03; CON: 3.27 ± 0.97, p < 268 
0.01) and R2pre (WBC: 3.03 ± 1.39; CON: 2.68 ± 0.61, p < 0.01) compared 269 
to baseline (WBC: 1.49 ± 0.42; CON: 1.44 ± 0.39). 270 
Despite an increase 24h after exercise (p < 0.01), CRP (Fig 2C) was not 271 
altered following WBC (intervention: p = 0.51; interaction: p = 0.94).  272 
sICAM-1 levels following the two treatments remained similar (Fig. 2D), with 273 
no intervention (p = 0.96) or interaction (p = 0.27) effects observed.  Despite 274 
observing a significant main effect for time (p < 0.01), no post-hoc 275 
differences (all p > 0.05) using the Bonferroni correction were detected.  276 
A significant increase over time (p < 0.01), but no intervention (p = 0.73) or 277 
interaction (p = 0.79) effect was observed in white blood cell count (Fig. 2E). 278 
Compared to baseline (WBC: 5.1 ± 1.4; CON: 5.4 ± 1.4) white blood cell 279 
count (·109·L-1) was elevated (all p < 0.01) at R1post (WBC: 6.4 ± 1.7; CON: 280 
6.3 ± 1.8) R2pre (WBC: 7.4 ± 1.9; CON: 7.0 ± 2.2), R2post (WBC: 10.7 ± 2.5; 281 
CON: 10.0 ± 2.3), 1h (WBC: 9.5 ± 2.4; CON: 9.3 ± 2.0) and 4h (WBC: 9.1 ± 282 
2.1; CON: 8.7 ± 1.6). 283 
3.2 Muscle damage 284 
There was a significant increase in myoglobin [ng·mL-1] over time (p < 0.01; 285 
Fig. 2F); however no significant intervention (p = 0.36) or interaction (p = 286 
0.73) effects were observed. Compared to baseline (WBC: 39.5 ± 7.7; CON: 287 
39.8 ± 10.0) myoglobin was elevated at R1post (WBC: 81.7 ± 26.2; CON: 84.5 288 
± 27.0), R2pre (WBC: 94.1 ± 35.3; CON: 113.6 ± 52.8), R2post (WBC: 93-6 ± 289 
33.4; CON: 115.9 ± 64.3), 1h (WBC: 124.9 ± 52.2; CON: 158.0 ± 108.3) and 290 
4h (WBC: 95.9 ± 31.4; CON: 123.0 ± 95.8) (all p < 0.01). 291 
*** Figure 2 near here*** 292 
3.3 Hormonal response 293 
A significant main effect over time was also overserved for cortisol (p < 0.01; 294 
Fig 3A), testosterone (p < 0.01; Fig 3B), and testosterone to cortisol ratio (p 295 
< 0.01; Fig 3C). Specifically, compared to baseline (WBC: 158.7 ± 26.7; 296 
CON: 167.0 ± 29.8) cortisol (ng·mL-1) was elevated (all p < 0.01) after the 297 
first ramp test (WBC: 217.9 ± 48.6; CON: 224.0 ± 58.2), at 1h (WBC: 115.6 298 
± 29.3; CON: 130.5 ± 14.6), 4h (WBC: 48.7 ± 18.4; CON: 62.8 ± 29.1)  and 299 
24h (WBC: 87.1 ± 20.3; CON: 89.0 ± 26.2). Compared to baseline (WBC: 300 
5.2 ± 1.4; CON: 5.4 ± 1.9) testosterone (ng·mL-1) was also elevated (all p < 301 
0.01) after the first ramp test (WBC: 6.4 ± 2.2; CON: 7.0 ± 2.1), at 1h (WBC: 302 
4.0 ± 1.1; CON: 4.2 ± 1.4)  and 4h (WBC: 3.2 ± 1.2; CON: 3.8 ± 1.3). Analysis 303 
of the testosterone to cortisol ratio indicated that, compared to baseline 304 
(WBC: 0.34 ± 0.11; CON: 0.35 ± 0.19) values increased significantly at 4h 305 
(WBC: 0.80 ± 0.52; CON: 0.81 ± 0.54, p < 0.01) and 24h (WBC: 0.63 ± 0.21; 306 
CON: 0.72 ± 0.47, p < 0.01). Again, no significant intervention or intervention 307 
* time interaction was overserved for cortisol (p = 0.53 and p = 0.93 308 
respectively), testosterone (p = 0.67 and p = 0.81 respectively), and the 309 
testosterone to cortisol ratio (p = 0.84 and p = 0.98 respectively). 310 
*** Figure 3 near here*** 311 
 312 
3.4 Correlation 313 
Performance decrements (Δtlim) correlated significantly with Δcortisol after 314 
both the CON (r = -0.64, p = 0.04) and the WBC interventions (r = -0.61, p = 315 
0.04; Fig. 4). No statistically significant correlations were detected for Δtlim 316 
and the change in any of the other biomarkers (all p > 0.05).  317 
*** Figure 4 near here*** 318 
*** Table 1 near here*** 319 
4. DISCUSSION 320 
The current study is the most thorough investigation of the acute effects (up 321 
to 24 hrs) of a single WBC-session following intermittent high-intensity 322 
exercise on hormonal, inflammatory and muscle damage biomarkers to 323 
date. The main findings of this investigation are as follows: (1) contrary to 324 
our initial hypothesis, compared to passive recovery one session of WBC 325 
did not alter the exercise-induced inflammatory, muscle damage or 326 
hormonal response to high-intensity running in trained athletes, (2) the 327 
exercise-induced perturbations of all inflammatory, muscle damage, and 328 
hormonal biomarkers, except CRP and testosterone to cortisol ratio, 329 
returned to basal levels within 24 hrs, and (3) increased levels of cortisol, 330 
induced by high-intensity exercise, were negatively correlated to subsequent 331 
running performance. Collectively, these data suggest that the postulated 332 
physiological mechanism(s), i.e. reductions in inflammation and muscle 333 
damage, by which WBC is purported to enhance recovery from EIMD 334 
following high-intensity running in trained male athletes may not be accurate.  335 
Reducing the inflammatory response following exercise is one of the primary 336 
reasons why WBC is applied as a recovery method [2]. In the present study, 337 
similar inflammatory responses were observed following WBC and the 338 
control intervention, with IL-6 and IL-10 peaking immediately after exercise 339 
and returning to baseline after 1-4 hrs post-exercise (see Fig 2). Pournot and 340 
colleagues [19] have previously reported comparable IL-6 and IL-10 341 
reactions following a simulated trail run on a treadmill in 11 well-trained 342 
distance runners. While exercise duration was longer in our investigation 343 
(56.3 ± 1.6 min vs 48 min), we did not include downhill running, that is known 344 
to induce severe structural muscle damage and inflammation due to high 345 
muscular load during eccentric contractions [13]. Selfe and colleagues [27] 346 
also reported similar IL-6 values to those of the present investigation and no 347 
effects of WBC on IL-6 concentration applied 10-16 hrs after a rugby training. 348 
Interestingly, another study reported reduced IL-6 values after 40-min of 349 
cycling in professional volleyball players following one session of WBC 350 
compared to no WBC and the authors suggested that WBC might initiate 351 
protective effects [28]. As WBC preceded exercise, it is likely that these 352 
methodological differences caused the differences in the cytokine profile 353 
compared to the present study.  354 
Despite a main effect over time, sICAM-1 was not altered following the WBC 355 
intervention (see Fig. 2). Thus, assuming sICAM-1 plays a key-role in the 356 
inflammation response [5,14], the present data suggest that a single session 357 
of WBC is insufficient to reduce the exercise-induced inflammation. Banfi 358 
and colleagues [29] have previously reported reduced levels of sICAM-1 359 
after five daily WBC- sessions in rugby players, yet due to the absence of a 360 
control group, it is difficult to delineate if WBC in isolation was responsible 361 
for these findings [29]. In contrast, Both Dugué and Leppänen [30] and 362 
Buemi and colleagues [31] reported increased levels of sICAM-1 after the 363 
application of cold water immersion. There is a brevity of empirical data 364 
investigating the effects of WBC on the sICAM-1, especially repeated 365 
exposures, thus this topic warrants further investigation [5,14].  366 
In comparison to the control condition, WBC did not alter CRP (see Fig. 2). 367 
Similarly, no effect of WBC on CRP response was reported in rugby players 368 
after five days with continuous training and daily WBC- treatments [32]. 369 
Contrary, Pournot and colleagues observed reduced CRP-levels 24 hrs after 370 
one session of WBC (3 min at -110°C) compared to passive recovery in 371 
equally trained participants  [19]. Overall higher CRP-values compared to 372 
our results are most likely caused by additional eccentric contractions during 373 
downhill running. Furthermore, Pournot reported decreased levels in pro-374 
inflammatory cytokine IL-1β and increased levels in anti-inflammatory 375 
cytokine IL-1ra, suggesting, in contrast to our findings, that one session of 376 
WBC reduces the inflammatory process [19]. 377 
CK is probably the most frequently analyzed biomarker to identify muscle 378 
damage [33]. CK only leaks into the bloodstream when the sarcolemma is 379 
damaged and is, therefore, another commonly used biomarker of muscle 380 
damage [34]. However, the enzyme has a molecular mass of 84 kilodaltons 381 
(kDa) and has to be transported by the lymphatic system [6]. Therefore, the 382 
onset of CK-concentration in venous blood is delayed. - Depending on the 383 
magnitude of muscle damage, CK peaks 24 to 96 hrs after exercise [35]. 384 
Therefore myoglobin, a rather small molecule (18 kDa) that is released 385 
directly to the blood flow as a result of degradation of muscle proteins [34], 386 
appears to be more feasible to detect the acute muscle damage effects of 387 
strenuous exercise. Myoglobin typically peaks within the first hours after 388 
severe exercise and is already decreasing at 24 hrs post exercise whereas 389 
CK is still rising [36,37]. To the best of our knowledge, this is the first 390 
investigation that has utilized myoglobin as marker for muscle damage after 391 
WBC. Myoglobin peaked 1 hr after exercise and returned to baseline after 392 
24 hrs with no differences between recovery modalities (see Fig 2).  393 
Although this is the first study to assess myoglobin, others have reported 394 
comparable results regarding CK [13,20], but also reduced levels of CK after 395 
WBC [3,18,38–40] [13,20]. However, these studies have some limitations, 396 
such as small sample size [38], the lack of a control group [40] or the high 397 
probability that the results were influenced by the repeated bout effect 398 
[18,39]. Therefore, the evidence for WBC to reduce muscle damage remains 399 
very limited. 400 
Testosterone, cortisol, and their ratio are often employed as biomarkers of 401 
anabolic status, training responses/adaptations and motivation [41]. It is well 402 
established that cortisol increases when an individual is exposed to 403 
psychophysiological stress following activation of the hypothalamic-pituitary-404 
adrenal axis [42]. The physical exercise itself potentially increases cortisol 405 
further, though the magnitude depends on, amongst other variables, the type 406 
of exercise [43] and the environmental conditions [44] where it takes place. 407 
In the present study we observed increased levels in cortisol at baseline and 408 
exercise induced increments in cortisol and testosterone, respectively (see 409 
Fig 3). Due to heterogeneous methodologies and conflicting results in the 410 
current literature, the effects of WBC on hormone biomarkers is still unclear 411 
[38,45–47]. However, to our knowledge there is only one study which has 412 
investigated the effects of a single WBC-session, applied immediately after 413 
exercise, on cortisol and testosterone [20]. In line with the findings of the 414 
present study, Russell and colleagues [20] detected no WBC- related 415 
changes in cortisol. Collectively, these findings suggest that a single WBC-416 
session does not alter the stress-related hormone cortisol. However, in 417 
contrast to our findings Russell and colleagues [20] reported increased 418 
testosterone levels in the WBC- group, suggesting that higher testosterone-419 
concentrations may facilitate recovery.[20]. Moreover, the authors speculate 420 
that higher testosterone- values might indicate reduced inflammation as low 421 
serum- testosterone concentrations are related to inflammation [20]. These 422 
results and speculations cannot be confirmed by the findings of the present 423 
investigation, as testosterone responded similarly after the WBC and CON-424 
interventions. The contrasting findings might be explained by the application 425 
of different exercise protocols. Immediately after repeated sprint exercise, 426 
Russell et al [20] detected no time effects in cortisol or testosterone, while 427 
our data indicated significant elevations in both hormones, most likely due 428 
to higher intensity of the exercise intervention. Therefore, it is plausible to 429 
speculated that testosterone concentrations are only elevated by one 430 
session of WBC if the preceding exercise itself did not induce a significant 431 
hormonal response.  432 
The present study also investigated the relationship between the 433 
performance decrements after HIR (i.e. Δ tlim R1 – R2) and the changes in 434 
biomarker-levels from baseline to the end of 60 min recovery period (R2pre 435 
– R1pre). No correlations were found for all biomarkers except cortisol, 436 
regardless of the recovery modality applied (see Fig. 4). These results 437 
suggest that reductions in cortisol after exercise and recovery lead to higher 438 
subsequent running-performance. Interestingly, despite no significant 439 
intervention or interaction effects in inflammatory, muscle damage and 440 
stress-related biomarkers, we observed improved running performance 441 
(time to exhaustion) immediately after a single WBC-session [16]. It can be 442 
speculated that these performance improvements are most likely attributed 443 
to i) a placebo effect, ii) perceptual reductions in pain, iii) acute changes in 444 
muscle oxygenation, iv) lower cardiovascular strain, or v) a combination of 445 
these factors.  446 
 447 
5. LIMITATIONS 448 
Our study has limitations that warrant mention. Firstly, incorporating a range 449 
of other inflammatory cytokines (e.g. TNF-alpha, IL-8 and IL-15), and 450 
biomarkers of muscle damage (e.g. creatine kinase, lactate dehydrogenase) 451 
and stress (e.g. epinephrine, alpha amylase) would have provided further 452 
insight into the inflammatory, damage, and hormonal effects of a single WBC 453 
exposure following exercise. Secondly, despite all biomarkers except CRP 454 
and testosterone-cortisol ratio returning to basal levels a longer timeline of 455 
analysis, possibly up to 96 hrs post exercise, would have offered additional 456 
insights into the potential effects of WBC. Thirdly, although the present 457 
investigation focused on inflammatory, hormonal and muscle damage 458 
biomarkers, functional and performance measures up to 24 hrs would have 459 
added additional practical information regarding the application of WBC. 460 
Fourthly, despite employing a cross-over study design, it is possible that the 461 
small sample-size increased the potential for type II error. Furthermore, a 462 
cross-over study design might be influenced by the repeated bout effect. 463 
However, due to the participants being very familiar with the exercise 464 
protocol and the lack of any unaccustomed exercise or downhill running, i.e. 465 
eccentric muscle damage, it is very unlikely that these results were impacted 466 
by the repeated bout effect. Future research incorporating a parallel design 467 
with a larger sample size is therefore warranted. Finally, not including an 468 
active recovery group is a limitation of this study. 469 
 470 
6. CONCLUSION 471 
This study is the most thorough investigation of the effects of a single 472 
session of WBC (3 min at -110°C) on biomarkers of hormonal status, 473 
inflammation, and muscle damage after acute high-intensity exercise in 474 
trained males. Despite the expected changes in IL-6, IL-10, CRP, sICAM-1, 475 
myoglobin, cortisol, testosterone, and cortisol-testosterone ratio in the 24 hrs 476 
following exercise, and contrary to our hypotheses, our results demonstrate 477 
for the first time that WBC has no acute beneficial effect compared to passive 478 
recovery in any biomarker assessed. The results of this study suggest that 479 
the postulated physiological mechanisms by which a single exposure to 480 
WBC is speculated to improve recovery, i.e. reductions in inflammation and 481 
muscle damage, may not be accurate. 482 
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Figure captions 492 
Figure 1. Schematic presentation of the experimental randomized cross 493 
over design.   denotes blood sampling at seven time points, before 494 
and after ramp test 1 (R1pre; R1post) and 2 (R2pre; R2post) and 1 (1h), 4 (4h) 495 
and 24 (24h) hrs after the intervention for whole-body cryotherapy (WBC) 496 
and control (CON) intervention, respectively.  497 
Figure 2. Serum concentrations (mean ± SD) of interleukin 6 (IL-6; A), 498 
interleukin 10 (IL-10; B), C-reactive Protein (CRP; C), soluble intercellular 499 
adhesion molecule-1 (sICAM-1; D) and myoglobin (F) as well as white blood 500 
cell count (WBC-count; E) at seven time points (R1pre; R1post; R2pre; R2post; 501 
1h; 4h; 24h). * P < 0.05 time effect compared to baseline (R1pre), for both 502 
interventions (whole-body cryotherapy (WBC) and control (CON)) 503 
combined. 504 
Figure 3. Serum concentrations (mean ± SD) of cortisol (A), testosterone 505 
(B) and calculation of testosterone to cortisol ratio (C) at seven time points 506 
(R1pre; R1post; R2pre; R2post; 1h; 4h; 24h). * P < 0.05 time effect compared to 507 
baseline (R1pre), for both interventions (whole-body cryotherapy [WBC] and 508 
control [CON]) combined. 509 
Figure 4. Correlations between change (Δ) in time to exhaustion (tlim) from 510 
ramp 1 to ramp 2 and change in serum cortisol from R1pre to R2pre in control 511 
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